---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-452706"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2026-11-09T13:04:59+00:00"
generated_at: "2026-11-09T13:10:37.336381+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Mentari Therapeutics closes InMed merger, raises $490M; MTRI begins Nasdaq trading Nov 9

## Summary
- Merger with InMed Pharmaceuticals completed; combined company is Mentari Therapeutics, trading on the Nasdaq Capital Market under ticker MTRI from Nov 9, 2026.
- Private financings totaled ~$490M gross, led by Fairmount, with Venrock, Blackstone, RTW, Wellington, a16z Bio + Health and others; includes conversion of $50.0M of convertible notes.
- ~58.3M shares and common stock equivalents outstanding after reverse split, financings and merger (excluding equity awards); proceeds fund runway into 2029 and beyond.
- MT-001 anti-PACAP monoclonal antibody in Phase 1 with initial data expected mid-2027; MT-002 PACAP/CGRP bispecific on track for regulatory filing Q1 2027, data by year-end 2027.
- Greg Divis is CEO of the combined company; Todd Shegog appointed to the board as Audit Committee chair in connection with the closing.

## SEC filing metadata
- accession: 0001193125-26-452706
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2026-11-09T13:04:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000119312526452706/0001193125-26-452706-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000119312526452706/d183007d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-452706
- JSON: https://secwatch.observer/filing/0001193125-26-452706.json
- Plain text: https://secwatch.observer/filing/0001193125-26-452706.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.